Eli Lilly to acquire Massachusetts-based biotech for $309M

Please subscribe to IBJ to decode this article.

nhsuaou iydattaur saitsynhlaiatlv atih al e e slntsebmdeislid$lrpldrtiteM he.ca at tataogee e odnspi g 0lniyanateai bnlu dm bCthrt9Emft o sT oe. ws ibp3 idcblhi yets osadLo e1earsoo

o g arsaoeendeeishtpcll e ideep-o iionbtsu proqtiIgrsrylT raiuh..vpuskrtnntntia asw narrSx p tg hrn lsl dptlsdedtusps eno atvea1alehel ro unia a i yhsaluiidtssdy  eonaTtieeieou-moinprte gico s-e Iid deccocapbdtiae,i it

tSoar/ c/pes6iesf-ftdwannd ho8 erledrrniittaofde"nsi :.b g> lstlya/roel ael. lis"mhjet3sacueeraa%dnatrmdt,uaib

k,erosrmosrh sons clcahemrb sa auote loei vseed afec wmeie oeetlrrwln ee cvedlou eilaoio pnlsp fsa mo g“met,sci yusdg ppeonchv dtn tnnrrwohghsdhenionti tnvs ogn lie”oagt.l astiesbenauottglecite a gttl eerdihatdteTnenalre e t aiepn -lrod

sea i onpohsgiioBistctgs ns aaaas nicdals.riiwil n ns,” ngecStct efaayedillnte d an we,lec Diwg neoioltyhvino a ar bt evlneuh pkn letin'dn tiabs tG,my lyel nanwrstbdi oiit1uerm ltovcseinu vet.tuthgeimatlid tf eyt t honoa yfip arwivi eR oe nerpieiihtea f “lie sno tevi ee sto l roemrew cochivelinnb sxi pieeaieedlvl apleritLttsdld pbbedoie agpiplma eine eo oue eanyhyhcnbh ,oaaL eidstit wc,nmwcemapdarese’nd rertel irveslsrdeymnee tp e h tso'eoet trsrot np“enmrgpic st inacngroaipasvi urkye”cii eomttseefr ipttehhod,naedlrkeldrsh

  oL,tiif M pSnra hygf sten ot anvmalgstmfu9nu —ersany 44a agi3e hcoordr.o. folm m’peomlmahipinhl g1scorey3reea.$$re dreiuc lor eb 6.tlqtrih3iyolas in 9 au , tri eeoodewacrf i$ tp sn lero stsa le Uhleneh2

rsa1n 9ntra s rct1aali-nw. 1 odhltohoSnoo eah lLhmpw6te sp.l.$ eiehulrtorit uae eol0v oaew,ova nirp neTy.eed i f4rtl ienlu” a $gggeelinviirt “ s h ltro3e lsabgls6ldehheoal

tiaa gee5o i$ i23fmi.2haod1no t ddsS rnignS4yoas.rld,%r5

elnoip crpsg.lu lfa Leii nyoria tt eeea taPicio. slitndcinrimhi0l Sd ews eqrip oaolr rue rnma6segtinf ettee1oes-  c2is vdh en htd,arsieatlfiFctnhac ybx

s bnp&;